| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014242278 |
| P356 | DOI | 10.1023/B:MCBI.0000049376.50242.7F |
| P698 | PubMed publication ID | 15663199 |
| P50 | author | Gabriel Rabinovich | Q17987510 |
| Marta A Toscano | Q130239222 | ||
| Mercedes Fuertes | Q37841931 | ||
| Norberto Zwirner | Q42880727 | ||
| Juan M. Ilarregui | Q44762461 | ||
| P2093 | author name string | Leonardo Fainboim | |
| Natalia Rubinstein | |||
| Luciana L Molinero | |||
| P2860 | cites work | Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 | Q28144624 |
| Potential roles of galectins in myeloid differentiation into three different lineages | Q28201112 | ||
| Ah, sweet mystery of death! Galectins and control of cell fate | Q28203010 | ||
| Biological activities of ecalectin: a novel eosinophil-activating factor | Q28217186 | ||
| Specificity and mechanism of action of some commonly used protein kinase inhibitors | Q28344791 | ||
| Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells | Q28511057 | ||
| Identification of a novel inhibitor of mitogen-activated protein kinase kinase | Q29616448 | ||
| Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation | Q29617586 | ||
| Galectins: a new family of regulators of inflammation | Q30616505 | ||
| Organization and regulation of mitogen-activated protein kinase signaling pathways | Q33333640 | ||
| Transcriptional regulation of T lymphocyte development and function | Q33652463 | ||
| Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. | Q51011747 | ||
| Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. | Q52529596 | ||
| Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis | Q58846453 | ||
| Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation | Q72345342 | ||
| Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages | Q72772895 | ||
| Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice | Q73401711 | ||
| Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms | Q74183464 | ||
| Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis | Q74385158 | ||
| Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization | Q74557548 | ||
| Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28 | Q78058070 | ||
| Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells | Q78127309 | ||
| Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 | Q78127337 | ||
| God must love galectins; he made so many of them | Q33751857 | ||
| Signal transduction by the TCR for antigen | Q33898927 | ||
| Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? | Q34693483 | ||
| Role of galectins in inflammatory and immunomodulatory processes | Q34837944 | ||
| Introduction to galectins | Q35646606 | ||
| Galectin genes: regulation of expression. | Q35646610 | ||
| Expression of galectins in cancer: a critical review | Q35646652 | ||
| Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses. | Q35646664 | ||
| Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. | Q35798551 | ||
| Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis | Q36375186 | ||
| Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. | Q36560044 | ||
| Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. | Q37367583 | ||
| Progress in deciphering the information content of the 'glycome'--a crescendo in the closing years of the millennium | Q38299610 | ||
| Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes | Q38301765 | ||
| Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. | Q38309944 | ||
| Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells | Q38316354 | ||
| Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells | Q38334060 | ||
| Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. | Q38361325 | ||
| Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn. | Q39451191 | ||
| Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival | Q39529473 | ||
| Transmembrane signaling by the interleukin-2 receptor: progress and conundrums | Q40790156 | ||
| Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction | Q40848658 | ||
| The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution | Q40860039 | ||
| Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells | Q40886933 | ||
| T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes. | Q40978696 | ||
| Expression of the L14 lectin during mouse embryogenesis suggests multiple roles during pre- and post-implantation development | Q42612637 | ||
| Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration | Q43890804 | ||
| Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages | Q44355242 | ||
| Galectin-1 suppresses experimental colitis in mice | Q44429812 | ||
| Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins | Q44466555 | ||
| Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis | Q44508461 | ||
| The sugar code in drug delivery | Q44768275 | ||
| Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. | Q46031717 | ||
| Apoptosis of T cells mediated by galectin-1. | Q46356564 | ||
| Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | Q47860342 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 177-185 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase | |
| P478 | volume | 267 |
| Q38081185 | 'Sweetening' pregnancy: galectins at the fetomaternal interface |
| Q61449796 | Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity |
| Q39373463 | Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372. |
| Q47684869 | Decidual T Cells Exhibit a Highly Differentiated Phenotype and Demonstrate Potential Fetal Specificity and a Strong Transcriptional Response to IFN. |
| Q37676907 | Endogenous galectin-1 exerts tonic inhibition on experimental arthritis |
| Q33631354 | Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma |
| Q59805634 | Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities |
| Q46864651 | Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells |
| Q103002570 | Galectin-1 is associated with the severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography |
| Q40131199 | Galectin-1-Driven Tolerogenic Programs Aggravate Yersinia enterocolitica Infection by Repressing Antibacterial Immunity |
| Q47381420 | Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation |
| Q35919323 | Galectin-1: a biomarker of surgical stress in murine model of cardiac surgery |
| Q36135442 | Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease |
| Q58707479 | Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update |
| Q37290930 | Mammalian glycosylation in immunity |
| Q37785133 | Multiple functional targets of the immunoregulatory activity of galectin-1: Control of immune cell trafficking, dendritic cell physiology, and T-cell fate. |
| Q34590952 | Nanotopographical control of stem cell differentiation. |
| Q37416956 | Severe preeclampsia is characterized by increased placental expression of galectin-1 |
| Q95650705 | Smart ultrasound-triggered doxorubicin-loaded nanoliposomes with improved therapeutic response: A comparative study |
| Q99711563 | T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells |
| Q55349770 | The Role of Galectins as Modulators of Metabolism and Inflammation. |
| Q42507942 | The association between oxidative stress-induced galectins and differentiation of human promyelocytic HL-60 cells |
| Q36292670 | The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders |
| Q54643114 | The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. |
| Q37976826 | The effect of galectins on leukocyte trafficking in inflammation: sweet or sour? |
| Q37443866 | Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation |
Search more.